Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Optic nerve oedema at high altitude occurs independent of acute mountain sickness.

Schatz A, Guggenberger V, Fischer MD, Schommer K, Bartz-Schmidt KU, Gekeler F, Willmann G.

Br J Ophthalmol. 2018 Jul 4. pii: bjophthalmol-2018-312224. doi: 10.1136/bjophthalmol-2018-312224. [Epub ahead of print]

PMID:
29973364
2.

Implantation, removal and replacement of subretinal electronic implants for restoration of vision in patients with retinitis pigmentosa.

Gekeler K, Bartz-Schmidt KU, Sachs H, MacLaren RE, Stingl K, Zrenner E, Gekeler F.

Curr Opin Ophthalmol. 2018 May;29(3):239-247. doi: 10.1097/ICU.0000000000000467. Review.

PMID:
29528862
3.

Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: results from the TESOLAUK trial.

Wagner SK, Jolly JK, Pefkianaki M, Gekeler F, Webster AR, Downes SM, Maclaren RE.

BMJ Open Ophthalmol. 2017 Dec 14;2(1):e000096. doi: 10.1136/bmjophth-2017-000096. eCollection 2017.

4.

Optical Coherence Tomography in Patients With the Subretinal Implant Retina Implant Alpha IMS.

Kuehlewein L, Kitiratschky V, Gosheva M, Edwards TL, MacLaren RE, Groppe M, Kusnyerik A, Soare C, Jackson TL, Sun CH, Chee C, Sachs H, Stingl K, Wilhelm B, Gekeler F, Bartz-Schmidt KU, Zrenner E, Stingl K.

Ophthalmic Surg Lasers Imaging Retina. 2017 Dec 1;48(12):993-999. doi: 10.3928/23258160-20171130-06.

PMID:
29253302
5.

Estimated incidence of high altitude retinal hemorrhages.

Willmann G, Schatz A, Gekeler F, Schultheiss M.

Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):231-232. doi: 10.1007/s00417-017-3795-6. Epub 2017 Sep 7. No abstract available.

PMID:
28879420
6.

Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations.

Stingl K, Schippert R, Bartz-Schmidt KU, Besch D, Cottriall CL, Edwards TL, Gekeler F, Greppmaier U, Kiel K, Koitschev A, Kühlewein L, MacLaren RE, Ramsden JD, Roider J, Rothermel A, Sachs H, Schröder GS, Tode J, Troelenberg N, Zrenner E.

Front Neurosci. 2017 Aug 23;11:445. doi: 10.3389/fnins.2017.00445. eCollection 2017.

7.

Effect of High Altitude Exposure on Intraocular Pressure Using Goldmann Applanation Tonometry.

Willmann G, Schommer K, Schultheiss M, Fischer MD, Bartz-Schmidt KU, Gekeler F, Schatz A.

High Alt Med Biol. 2017 Jun;18(2):114-120. doi: 10.1089/ham.2016.0115. Epub 2017 Mar 23.

PMID:
28333563
8.

Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year.

Schatz A, Pach J, Gosheva M, Naycheva L, Willmann G, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Messias A, Gekeler F.

Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):257-269. doi: 10.1167/iovs.16-19906.

PMID:
28114587
9.

[The effect of high altitude on the ocular surface].

Willmann G, Gekeler F.

Ther Umsch. 2017;74(10):564-568. doi: 10.1024/0040-5930/a000957. Review. German. No abstract available.

PMID:
29690835
10.

[Transcorneal electrical stimulation in primary open angle glaucoma].

Röck T, Naycheva L, Willmann G, Wilhelm B, Peters T, Zrenner E, Bartz-Schmidt KU, Gekeler F, Schatz A.

Ophthalmologe. 2017 Oct;114(10):922-929. doi: 10.1007/s00347-016-0415-5. German.

PMID:
27966032
11.

A Novel Method for Quantitative Serial Autofluorescence Analysis in Retinitis Pigmentosa Using Image Characteristics.

Jolly JK, Wagner SK, Moules J, Gekeler F, Webster AR, Downes SM, MacLaren RE.

Transl Vis Sci Technol. 2016 Dec 1;5(6):10. eCollection 2016 Dec.

12.

Transfer characteristics of subretinal visual implants: corneally recorded implant responses.

Stingl K, Bartz-Schmidt KU, Braun A, Gekeler F, Greppmaier U, Schatz A, Stett A, Strasser T, Kitiratschky V, Zrenner E.

Doc Ophthalmol. 2016 Oct;133(2):81-90. Epub 2016 Aug 10.

13.

Author Response: Subfoveal Choroidal Thickness in High-Altitude Mountaineers.

Fischer MD, Schatz A, Gekeler F, Willmann G.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1748. doi: 10.1167/iovs.16-19439. No abstract available.

PMID:
27064396
14.

Extraocular Surgical Approach for Placement of Subretinal Implants in Blind Patients: Lessons from Cochlear-Implants.

Koitschev A, Stingl K, Bartz-Schmidt KU, Braun A, Gekeler F, Greppmaier U, Sachs H, Peters T, Wilhelm B, Zrenner E, Besch D.

J Ophthalmol. 2015;2015:842518. doi: 10.1155/2015/842518. Epub 2015 Dec 10.

15.

[Ocular electrical stimulation: Therapeutic application and active retinal implants for hereditary retinal degenerations].

Gekeler F, Zrenner E, Bartz-Schmidt KU.

Ophthalmologe. 2015 Sep;112(9):712-9. doi: 10.1007/s00347-015-0126-3. Review. German.

PMID:
26319085
16.

[Secondary Intraocular Lens Implantation].

Gekeler K, Gekeler F.

Klin Monbl Augenheilkd. 2015 Aug;232(8):1003-20; quiz 1021-2. doi: 10.1055/s-0033-1358165. Epub 2015 Aug 19. Review. German. No abstract available.

PMID:
26287546
17.

Reversible Increase of Central Choroidal Thickness During High-Altitude Exposure.

Fischer MD, Schatz A, Seitz IP, Schommer K, Bartz-Schmidt KU, Gekeler F, Willmann G.

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4499-503. doi: 10.1167/iovs.15-16770.

PMID:
26200487
18.

[The role of the vitreous body in diseases of neighboring structures].

Gekeler K, Priglinger S, Gekeler F, Priglinger C.

Ophthalmologe. 2015 Jul;112(7):564-71. doi: 10.1007/s00347-015-0056-0. Review. German.

PMID:
26142226
19.

Oculomotor behavior of blind patients seeing with a subretinal visual implant.

Hafed ZM, Stingl K, Bartz-Schmidt KU, Gekeler F, Zrenner E.

Vision Res. 2016 Jan;118:119-31. doi: 10.1016/j.visres.2015.04.006. Epub 2015 Apr 20.

20.

Subretinal Visual Implant Alpha IMS--Clinical trial interim report.

Stingl K, Bartz-Schmidt KU, Besch D, Chee CK, Cottriall CL, Gekeler F, Groppe M, Jackson TL, MacLaren RE, Koitschev A, Kusnyerik A, Neffendorf J, Nemeth J, Naeem MA, Peters T, Ramsden JD, Sachs H, Simpson A, Singh MS, Wilhelm B, Wong D, Zrenner E.

Vision Res. 2015 Jun;111(Pt B):149-60. doi: 10.1016/j.visres.2015.03.001. Epub 2015 Mar 23.

21.

In vivo biocompatibility of a new cyanine dye for ILM peeling.

Thaler S, Haritoglou C, Schuettauf F, Choragiewicz T, May CA, Gekeler F, Fischer MD, Langhals H, Schatz A.

Eye (Lond). 2015 Mar;29(3):428-35. doi: 10.1038/eye.2014.295. Epub 2014 Dec 19.

22.

Missing correlation of retinal vessel diameter with high-altitude headache.

Willmann G, Fischer MD, Schommer K, Bärtsch P, Gekeler F, Schatz A.

Ann Clin Transl Neurol. 2014 Jan;1(1):59-63. doi: 10.1002/acn3.18. Epub 2013 Nov 19.

23.

[Multifocal and add-on intraocular lenses].

Gekeler K, Gekeler F.

Klin Monbl Augenheilkd. 2014 Oct;231(10):1037, 1039-48; quiz 1049-50. doi: 10.1055/s-0033-1358020. Epub 2014 Oct 21. German. No abstract available.

PMID:
25333242
24.

Safety evaluation of "retina implant alpha IMS"--a prospective clinical trial.

Kitiratschky VB, Stingl K, Wilhelm B, Peters T, Besch D, Sachs H, Gekeler F, Bartz-Schmidt KU, Zrenner E.

Graefes Arch Clin Exp Ophthalmol. 2015 Mar;253(3):381-7. doi: 10.1007/s00417-014-2797-x. Epub 2014 Sep 16.

PMID:
25219982
25.

Exposure to high altitude alters tear film osmolarity and breakup time.

Willmann G, Schatz A, Fischer MD, Schommer K, Zrenner E, Bartz-Schmidt KU, Gekeler F, Gekeler K.

High Alt Med Biol. 2014 Jun;15(2):203-7. doi: 10.1089/ham.2013.1103.

PMID:
24971769
26.

Update on high altitude cerebral edema including recent work on the eye.

Willmann G, Gekeler F, Schommer K, Bärtsch P.

High Alt Med Biol. 2014 Jun;15(2):112-22. doi: 10.1089/ham.2013.1142. Review.

PMID:
24971765
27.

Attenuation of S-cone function at high altitude assessed by electroretinography.

Schatz A, Dominik Fischer M, Schommer K, Zrenner E, Bartz-Schmidt KU, Gekeler F, Willmann G.

Vision Res. 2014 Apr;97:59-64. doi: 10.1016/j.visres.2014.02.003. Epub 2014 Feb 24.

28.

Pupillary light reaction during high altitude exposure.

Schultheiss M, Schommer K, Schatz A, Wilhelm B, Peters T, Fischer MD, Zrenner E, Bartz-Schmidt KU, Gekeler F, Willmann G.

PLoS One. 2014 Feb 4;9(2):e87889. doi: 10.1371/journal.pone.0087889. eCollection 2014.

29.

Electroretinographic assessment of retinal function during acute exposure to normobaric hypoxia.

Schatz A, Breithaupt M, Hudemann J, Niess A, Messias A, Zrenner E, Bartz-Schmidt KU, Gekeler F, Willmann G.

Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(1):43-50. doi: 10.1007/s00417-013-2504-3. Epub 2013 Nov 6.

PMID:
24193351
30.

Functional outcome in subretinal electronic implants depends on foveal eccentricity.

Stingl K, Bartz-Schmidt KU, Gekeler F, Kusnyerik A, Sachs H, Zrenner E.

Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7658-65. doi: 10.1167/iovs.13-12835.

PMID:
24150759
31.
32.

Impact of acute exposure to high altitude on anterior chamber geometry.

Willmann G, Schatz A, Zhour A, Schommer K, Zrenner E, Bartz-Schmidt KU, Gekeler F, Fischer MD.

Invest Ophthalmol Vis Sci. 2013 Jun 21;54(6):4241-8. doi: 10.1167/iovs.13-12158.

PMID:
23737468
33.

Retinal vessel leakage at high altitude.

Willmann G, Fischer MD, Schatz A, Schommer K, Gekeler F.

JAMA. 2013 Jun 5;309(21):2210-2. doi: 10.1001/jama.2013.5550. No abstract available.

PMID:
23736726
34.

Electroretinographic assessment of retinal function at high altitude.

Schatz A, Willmann G, Fischer MD, Schommer K, Messias A, Zrenner E, Bartz-Schmidt KU, Gekeler F.

J Appl Physiol (1985). 2013 Aug 1;115(3):365-72. doi: 10.1152/japplphysiol.00245.2013. Epub 2013 May 30.

35.

Transcorneal electrical stimulation in patients with retinal artery occlusion: a prospective, randomized, sham-controlled pilot study.

Naycheva L, Schatz A, Willmann G, Bartz-Schmidt KU, Zrenner E, Röck T, Gekeler F.

Ophthalmol Ther. 2013 Jun;2(1):25-39. doi: 10.1007/s40123-013-0012-5. Epub 2013 Feb 15.

36.

[Therapeutic approaches for retinitis pigmentosa].

Pach J, Gekeler F.

Klin Monbl Augenheilkd. 2013 May;230(5):512-8. doi: 10.1055/s-0032-1328471. Epub 2013 May 21. Review. German.

PMID:
23695848
37.

Axonal electrovisiogram or inverse photopic skin electroretinogram?

Messias K, Castro VM, Gekeler F, Messias A.

Arq Bras Oftalmol. 2012 Oct;75(5):370-1. No abstract available.

38.

Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS.

Stingl K, Bartz-Schmidt KU, Besch D, Braun A, Bruckmann A, Gekeler F, Greppmaier U, Hipp S, Hörtdörfer G, Kernstock C, Koitschev A, Kusnyerik A, Sachs H, Schatz A, Stingl KT, Peters T, Wilhelm B, Zrenner E.

Proc Biol Sci. 2013 Feb 20;280(1757):20130077. doi: 10.1098/rspb.2013.0077. Print 2013 Apr 22.

39.

Fluorescein angiographic findings in eyes of patients with a subretinal electronic implant.

Stingl K, Gekeler F, Bartz-Schmidt KU, Kögel A, Zrenner E, Gelisken F.

Curr Eye Res. 2013 May;38(5):588-96. doi: 10.3109/02713683.2013.767349. Epub 2013 Feb 14.

PMID:
23410193
40.

[Effects of transcorneal electrical stimulation in patients with Stargardt's disease].

Röck T, Schatz A, Naycheva L, Gosheva M, Pach J, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Willmann G, Gekeler F.

Ophthalmologe. 2013 Jan;110(1):68-73. doi: 10.1007/s00347-012-2749-y. German.

PMID:
23329121
41.

Safety and efficacy of subretinal visual implants in humans: methodological aspects.

Stingl K, Bach M, Bartz-Schmidt KU, Braun A, Bruckmann A, Gekeler F, Greppmaier U, Hörtdörfer G, Kusnyerik A, Peters T, Wilhelm B, Wilke R, Zrenner E.

Clin Exp Optom. 2013 Jan;96(1):4-13. doi: 10.1111/j.1444-0938.2012.00816.x. Epub 2012 Nov 22. Review.

42.

Phosphene thresholds elicited by transcorneal electrical stimulation in healthy subjects and patients with retinal diseases.

Naycheva L, Schatz A, Röck T, Willmann G, Messias A, Bartz-Schmidt KU, Zrenner E, Gekeler F.

Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7440-8. doi: 10.1167/iovs.12-9612.

PMID:
23049087
43.

Transcorneal electrical stimulation shows neuroprotective effects in retinas of light-exposed rats.

Schatz A, Arango-Gonzalez B, Fischer D, Enderle H, Bolz S, Röck T, Naycheva L, Grimm C, Messias A, Zrenner E, Bartz-Schmidt KU, Willmann G, Gekeler F.

Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5552-61. doi: 10.1167/iovs.12-10037.

PMID:
22807300
44.

Response to: Non-invasive electrical brain stimulation induces vision restoration in patients with visual pathway damage.

Gekeler F, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):1045. doi: 10.1007/s00417-012-2085-6. Epub 2012 Jun 23. No abstract available.

PMID:
22729433
45.

Sulcus anatomy and diameter in pseudophakic eyes and correlation with biometric data: evaluation with a 50 MHz ultrasound biomicroscope.

Petermeier K, Suesskind D, Altpeter E, Schatz A, Messias A, Gekeler F, Szurman P.

J Cataract Refract Surg. 2012 Jun;38(6):986-91. doi: 10.1016/j.jcrs.2011.12.027.

PMID:
22624897
46.

Positioning of electronic subretinal implants in blind retinitis pigmentosa patients through multimodal assessment of retinal structures.

Kusnyerik A, Greppmaier U, Wilke R, Gekeler F, Wilhelm B, Sachs HG, Bartz-Schmidt KU, Klose U, Stingl K, Resch MD, Hekmat A, Bruckmann A, Karacs K, Nemeth J, Suveges I, Zrenner E.

Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3748-55. doi: 10.1167/iovs.11-9409.

PMID:
22562517
47.

Structural and functional changes of the human macula during acute exposure to high altitude.

Fischer MD, Willmann G, Schatz A, Schommer K, Zhour A, Zrenner E, Bartz-Schmidt KU, Gekeler F.

PLoS One. 2012;7(4):e36155. doi: 10.1371/journal.pone.0036155. Epub 2012 Apr 30.

48.

Effects of combined ketamine/xylazine anesthesia on light induced retinal degeneration in rats.

Arango-Gonzalez B, Schatz A, Bolz S, Eslava-Schmalbach J, Willmann G, Zhour A, Zrenner E, Fischer MD, Gekeler F.

PLoS One. 2012;7(4):e35687. doi: 10.1371/journal.pone.0035687. Epub 2012 Apr 25. Erratum in: PLoS One. 2012;7(8). doi:10.1371/annotation/d52a610e-6a56-4158-90bf-45e37f053567.

49.

Tempol protects against intravitreous indocyanine green-induced retinal damage in rats.

Thaler S, Voykov B, Willmann G, Fiedorowicz M, Rejdak R, Gekeler F, May CA, Schatz A, Schuettauf F.

Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1597-606. doi: 10.1007/s00417-012-2000-1. Epub 2012 Mar 31.

PMID:
22460632
50.

Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy.

Messias A, Ramos Filho JA, Messias K, Almeida FP, Costa RA, Scott IU, Gekeler F, Jorge R.

Doc Ophthalmol. 2012 Jun;124(3):225-36. doi: 10.1007/s10633-012-9322-5. Epub 2012 Mar 29.

PMID:
22457045

Supplemental Content

Loading ...
Support Center